Table 4

Point-of-care tests that at least 50% of respondents in at least one country would use, ranked in descending order according to total percentage of general practitioners that would use the tests

Australia (n=298)Belgium (n=319)The Netherlands (n=639)UK (n=1109)USA (n=405)Total (n=2770)
D-dimer41% (121)83% (265)70% (448)73% (811)62% (251)68% (1896)
Troponin43% (129)85% (271)65% (418)69% (765)59% (238)66% (1821)
Chlamydia49% (145)67% (212)60% (382)65% (721)66% (267)62% (1727)
B-type natriuretic peptide28% (82)51% (164)62% (398)66% (734)60% (244)59% (1622)
C reactive protein38% (114)75% (238)47% (302)61% (682)45% (181)55% (1517)
Gonorrhoea34% (100)56% (180)51% (326)58% (645)65% (262)55% (1513)
HbA1c52% (156)61% (195)37% (239)61% (679)50% (202)53% (1471)
White cell count43% (127)67% (212)40% (256)60% (661)52% (212)53% (1468)
Haemoglobin47% (139)47% (150)26% (168)72% (793)39% (159)51% (1409)
Potassium33% (97)47% (150)33% (210)61% (679)57% (232)49% (1368)
International normalised ratio21% (63)77% (244)54% (347)47% (517)43% (176)49% (1347)
Nose/throat swab for influenza43% (128)59% (187)36% (231)55% (609)33% (134)47% (1289)
Erythrocyte sedimentation rate29% (86)40% (128)29% (183)58% (645)48% (194)45% (1236)
Quantitative β-human chorionic gonadotropin40% (120)56% (177)23% (149)53% (586)46% (187)44% (1219)
Creatinine34% (102)41% (130)28% (177)53% (593)53% (214)44% (1216)
Thyroid stimulating hormone32% (95)33% (105)27% (171)53% (586)62% (253)44% (1210)
Throat swab for group A streptococci35% (103)60% (190)33% (208)53% (588)11% (45)41% (1134)
Uric acid28% (82)30% (94)26% (167)50% (549)51% (205)40% (1097)
Sodium30% (88)21% (66)19% (122)51% (571)42% (172)37% (1019)
  • HbA1c; glycated haemoglobin.